Latest filing published 05 Apr 2022 for Orthofix Medical Inc., €21k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Paul Gonsalves: trading record in brief
Paul Gonsalves, listed as chief executive, appears in our data through filings on Orthofix Medical Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 11 September 2020 and the latest from 1 April 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 5 April 2022 came the latest disclosure, a share grant for €21k in Orthofix Medical Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul Gonsalves
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 687 shares@ US$33.0436.4% of flowCommon StockSEC:0001209191-22-023347:0
- 9,836 shares0Common StockSEC:0001209191-22-006838:0
- 1,045 shares@ US$40.5963.6% of flowCommon StockSEC:0001209191-21-055721:0
3 of 3 declarations
